Rodent models of frailty and their application in preclinical research

被引:23
|
作者
Banga, Shubham [1 ]
Heinze-Milne, Stefan D. [1 ]
Howlett, Susan E. [1 ,2 ]
机构
[1] Dalhousie Univ, Dept Pharmacol, 5850 Coll St,POB 15000, Halifax, NS B3H 4R2, Canada
[2] Dalhousie Univ, Dept Med Geriatr Med, Halifax, NS, Canada
关键词
Frailty index; Frailty phenotype; Interventions; Drug treatment; Deficit accumulation; DEFICIT ACCUMULATION; SEX-DIFFERENCES; OLDER-ADULTS; SKELETAL-MUSCLE; ANIMAL-MODELS; INDEX; MOUSE; AGE; HEART; MICE;
D O I
10.1016/j.mad.2019.01.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In clinical medicine, the concept of frailty is viewed as a state of high vulnerability to adverse health outcomes in people of the same age. Frailty is an important challenge because the loss of physiological reserve means that even minor stressors can lead to disability and death in those who are frail. Even so, the biology of frailty is not well understood. Rodent models of frailty are stimulating research into the biology of frailty. These pre-clinical models are based on "reverse-translation". Investigators have adapted either the "frailty phenotype" approach or the "frailty index" approach, originally developed in humans, for use in animals. This review briefly describes rodent models of frailty, discusses how these models have been used to explore mechanisms of frailty and how they have been employed to assess the impact of frailty on various experimental outcomes. The review also highlights studies that have used rodent models to investigate interventions to attenuate frailty, including drug treatment, dietary modifications and exercise. The ability to model frailty in animals is an exciting development that promises to accelerate the translation of laboratory discoveries into new clinical interventions, and situates frailty research in the larger context of geroscience.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [21] Novel Rodent Models for Macular Research
    Huber, G.
    Beck, S. C.
    Imsand, C.
    Heynen, S.
    Grimm, C.
    Feng, Y.
    Hammes, H. -P.
    Hoffmann, W.
    Scheurlen, U.
    Seeliger, M. W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [22] Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research
    Fritz, Brandon M.
    Boehm, Stephen L., III
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 65 : 297 - 308
  • [23] Preclinical Animal Models in Trauma Research
    Harvey, Edward J.
    Giannoudis, Peter V.
    Martineau, Paul A.
    Lansdowne, Jennifer L.
    Dimitriou, Rozalia
    Moriarty, Thomas Fintan
    Richards, Robert Geoffrey
    JOURNAL OF ORTHOPAEDIC TRAUMA, 2011, 25 (08) : 488 - 493
  • [24] Experimental models for preclinical cancer research
    Ma, Stephanie
    EXPERIMENTAL CELL RESEARCH, 2023, 429 (01)
  • [25] Preclinical models in heart failure research
    Aguero, J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 : 25 - 25
  • [26] Preclinical models for translational sarcoma research
    Hamacher, Rainer
    Bauer, Sebastian
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (04) : 275 - 285
  • [27] Rodent models of diabetic kidney disease: human translatability and preclinical validity
    Sembach, Frederikke E.
    Ostergaard, Mette, V
    Vrang, Niels
    Feldt-Rasmussen, Bo
    Fosgerau, Keld
    Jelsing, Jacob
    Fink, Lisbeth N.
    DRUG DISCOVERY TODAY, 2021, 26 (01) : 200 - 217
  • [28] Microcystin Toxicokinetics, Molecular Toxicology, and Pathophysiology in Preclinical Rodent Models and Humans
    Arman, Tarana
    Clarke, John D.
    TOXINS, 2021, 13 (08)
  • [29] Preclinical Evaluation of Fingolimod in Rodent Models of Stroke With Age or Atherosclerosis as Comorbidities
    Diaz, Andrea C. Diaz C.
    Malone, Kyle
    Shearer, Jennifer A.
    Moore, Anne C.
    Waeber, Christian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Preclinical Models for Bladder Cancer Research
    Zhu, Shaoming
    Zhu, Zheng
    Ma, Ai-Hong
    Sonpavde, Guru P.
    Cheng, Fan
    Pan, Chong-Xian
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (03) : 613 - 632